|
|
||||||||
The Journal of Immunology, Vol 159, Issue 10 4990-4998, Copyright © 1997 by American Association of Immunologists
ARTICLES |
K Mohan, P Moulin and MM Stevenson
Centre for the Study of Host Resistance, McGill University, Montreal General Hospital Research Institute, Quebec, Canada.
Our recent study showed that IL-12 treatment of susceptible A/J mice induces Th1-mediated, protective immunity against lethal blood-stage Plasmodium chabaudi AS infection. To further understand the mechanism of this protection, we examined NK cell cytotoxic (NKCC) and cytokine secretory functions in untreated and IL-12-treated A/J mice, along with resistant C57BL/6 (B6) mice. Normal A/J mice receiving six daily doses of 0.1 microg IL-12 exhibited significant increases in NKCC in total spleen cell populations. Defective NKCC evident in vitro in enriched NK cells from infected A/J mice was corrected by addition of 10 ng/ml IL- 12 and was comparable with that seen in B6 mice. In vivo and in vitro analyses revealed that enriched NK cells from day 6 infected A/J mice were defective not only in NKCC, but also in IFN-gamma, and to a certain extent, TNF-alpha secretion, which could also be corrected by IL-12 treatment. Depletion of NK cells from resistant B6 mice resulted in a more severe course of infection, while NK cell-depleted, IL-12- treated A/J mice had significantly higher parasitemia, as well as 100% mortality, suggesting the importance of NK cells in IL-12-mediated protection. NKCC-defective bg/bg mice produced optimum IFN-gamma and TNF-alpha and recovered from infection similar to bg/+ controls; in vivo depletion of these cytokines resulted in significantly higher parasitemia early in infection. Based on these results, we conclude that IFN-gamma, and possibly TNF-alpha, secretion by NK cells during early infection plays a major role in protective immunity to blood- stage malaria.
This article has been cited by other articles:
![]() |
M. Miyakoda, D. Kimura, M. Yuda, Y. Chinzei, Y. Shibata, K. Honma, and K. Yui Malaria-Specific and Nonspecific Activation of CD8+ T Cells during Blood Stage of Plasmodium berghei Infection J. Immunol., July 15, 2008; 181(2): 1420 - 1428. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Couper, D. G. Blount, J. C. R. Hafalla, N. van Rooijen, J. B. de Souza, and E. M. Riley Macrophage-Mediated but Gamma Interferon-Independent Innate Immune Responses Control the Primary Wave of Plasmodium yoelii Parasitemia Infect. Immun., December 1, 2007; 75(12): 5806 - 5818. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Hansen, N. J. Bernard, C. Q. Nie, and L. Schofield NK Cells Stimulate Recruitment of CXCR3+ T Cells to the Brain during Plasmodium berghei-Mediated Cerebral Malaria J. Immunol., May 1, 2007; 178(9): 5779 - 5788. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Roland, V. Soulard, C. Sellier, A.-M. Drapier, J. P. Di Santo, P.-A. Cazenave, and S. Pied NK Cell Responses to Plasmodium Infection and Control of Intrahepatic Parasite Development J. Immunol., July 15, 2006; 177(2): 1229 - 1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mavoungou Interactions between natural killer cells, cortisol and prolactin in malaria during pregnancy. Clin. Med. Res., March 1, 2006; 4(1): 33 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Korbel, K. C. Newman, C. R. Almeida, D. M. Davis, and E. M. Riley Heterogeneous Human NK Cell Responses to Plasmodium falciparum-Infected Erythrocytes J. Immunol., December 1, 2005; 175(11): 7466 - 7473. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Williams, A. R. Bateman, and S. I. Khakoo HANGING IN THE BALANCE: KIR and Their Role in Disease Mol. Interv., August 1, 2005; 5(4): 226 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ing, P. Gros, and M. M. Stevenson Interleukin-15 Enhances Innate and Adaptive Immune Responses to Blood-Stage Malaria Infection in Mice Infect. Immun., May 1, 2005; 73(5): 3172 - 3177. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Chagnon, S. Tanguay, O. L. Ozdal, M. Guan, Z. Z. Ozen, J.-S. Ripeau, M. Chevrette, M. M. Elhilali, and L. A. Thompson-Snipes Potentiation of a Dendritic Cell Vaccine for Murine Renal Cell Carcinoma by CpG Oligonucleotides Clin. Cancer Res., February 1, 2005; 11(3): 1302 - 1311. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Elias, L. R. Sardinha, K. R. B. Bastos, C. A. Zago, A. P. F. da Silva, J. M. Alvarez, and M. R. D. Lima Role of CD28 in Polyclonal and Specific T and B Cell Responses Required for Protection against Blood Stage Malaria J. Immunol., January 15, 2005; 174(2): 790 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. John, A. M. Moormann, P. O. Sumba, A. V. Ofulla, D. C. Pregibon, and J. W. Kazura Gamma Interferon Responses to Plasmodium falciparum Liver-Stage Antigen 1 and Thrombospondin-Related Adhesive Protein and Their Relationship to Age, Transmission Intensity, and Protection against Malaria Infect. Immun., September 1, 2004; 72(9): 5135 - 5142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saeftel, A. Krueger, S. Arriens, V. Heussler, P. Racz, B. Fleischer, F. Brombacher, and A. Hoerauf Mice Deficient in Interleukin-4 (IL-4) or IL-4 Receptor {alpha} Have Higher Resistance to Sporozoite Infection with Plasmodium berghei (ANKA) than Do Naive Wild-Type Mice Infect. Immun., January 1, 2004; 72(1): 322 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Artavanis-Tsakonas, K. Eleme, K. L. McQueen, N. W. Cheng, P. Parham, D. M. Davis, and E. M. Riley Activation of a Subset of Human NK Cells upon Contact with Plasmodium falciparum-Infected Erythrocytes J. Immunol., November 15, 2003; 171(10): 5396 - 5405. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Omer, J. B. de Souza, and E. M. Riley Differential Induction of TGF-{beta} Regulates Proinflammatory Cytokine Production and Determines the Outcome of Lethal and Nonlethal Plasmodium yoelii Infections J. Immunol., November 15, 2003; 171(10): 5430 - 5436. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Su, M.-F. Tam, D. Jankovic, and M. M. Stevenson Vaccination with Novel Immunostimulatory Adjuvants against Blood-Stage Malaria in Mice Infect. Immun., September 1, 2003; 71(9): 5178 - 5187. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Aguilar-Delfin, P. J. Wettstein, and D. H. Persing Resistance to Acute Babesiosis Is Associated with Interleukin-12- and Gamma Interferon-Mediated Responses and Requires Macrophages and Natural Killer Cells Infect. Immun., April 1, 2003; 71(4): 2002 - 2008. [Abstract] [Full Text] |
||||
![]() |
K. Artavanis-Tsakonas and E. M. Riley Innate Immune Response to Malaria: Rapid Induction of IFN-{gamma} from Human NK Cells by Live Plasmodium falciparum-Infected Erythrocytes J. Immunol., September 15, 2002; 169(6): 2956 - 2963. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Su and M. M. Stevenson IL-12 Is Required for Antibody-Mediated Protective Immunity Against Blood-Stage Plasmodiumchabaudi AS Malaria Infection in Mice J. Immunol., February 1, 2002; 168(3): 1348 - 1355. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Taylor, E. Seixas, M. J. Walport, J. Langhorne, and M. Botto Complement Contributes to Protective Immunity against Reinfection by Plasmodium chabaudi chabaudi Parasites Infect. Immun., June 1, 2001; 69(6): 3853 - 3859. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Eo, S. Lee, S. Chun, and B. T. Rouse Modulation of Immunity against Herpes Simplex Virus Infection via Mucosal Genetic Transfer of Plasmid DNA Encoding Chemokines J. Virol., January 15, 2001; 75(2): 569 - 578. [Abstract] [Full Text] |
||||
![]() |
J. D. Kurtis, R. Mtalib, F. K. Onyango, and P. E. Duffy Human Resistance to Plasmodium falciparum Increases during Puberty and Is Predicted by Dehydroepiandrosterone Sulfate Levels Infect. Immun., January 1, 2001; 69(1): 123 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Choudhury, N. A. Sheikh, G. J. Bancroft, D. R. Katz, and J. B. de Souza Early Nonspecific Immune Responses and Immunity to Blood-Stage Nonlethal Plasmodium yoelii Malaria Infect. Immun., November 1, 2000; 68(11): 6127 - 6132. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Su and M. M. Stevenson Central Role of Endogenous Gamma Interferon in Protective Immunity against Blood-Stage Plasmodium chabaudi AS Infection Infect. Immun., August 1, 2000; 68(8): 4399 - 4406. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yoshida, H. Maruyama, T. Kumagai, T. Amano, F. Kobayashi, M. Zhang, K. Himeno, and N. Ohta Schistosoma mansoni infection cancels the susceptibility to Plasmodium chabaudi through induction of type 1 immune responses in A/J mice Int. Immunol., August 1, 2000; 12(8): 1117 - 1125. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoneto, T. Yoshimoto, C.-R. Wang, Y. Takahama, M. Tsuji, S. Waki, and H. Nariuchi Gamma Interferon Production Is Critical for Protective Immunity to Infection with Blood-Stage Plasmodium berghei XAT but Neither NO Production nor NK Cell Activation Is Critical Infect. Immun., May 1, 1999; 67(5): 2349 - 2356. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mohan, H. Sam, and M. M. Stevenson Therapy with a Combination of Low Doses of Interleukin 12 and Chloroquine Completely Cures Blood-Stage Malaria, Prevents Severe Anemia, and Induces Immunity to Reinfection Infect. Immun., February 1, 1999; 67(2): 513 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sam and M. M. Stevenson In Vivo IL-12 Production and IL-12 Receptors {beta}1 and {beta}2 mRNA Expression in the Spleen Are Differentially Up-Regulated in Resistant B6 and Susceptible A/J Mice During Early Blood-Stage Plasmodium chabaudi AS Malaria J. Immunol., February 1, 1999; 162(3): 1582 - 1589. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Winkler, M. Willheim, K. Baier, D. Schmid, A. Aichelburg, W. Graninger, and P. G. Kremsner Reciprocal Regulation of Th1- and Th2-Cytokine-Producing T Cells during Clearance of Parasitemia in Plasmodium falciparum Malaria Infect. Immun., December 1, 1998; 66(12): 6040 - 6044. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |